Application Note: Next generation 3D patient-derived cell culture services
6 January 2020

In this overview, zPREDICTA demonstrates their 3D culture serivces based on their unique proprietary technology, where organ-specific extracellular matrix and disease-specific medium supplements provide a physiologically relevant microenvironment for accurate testing of anticancer compounds.

Company